Virbac Group, a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1968, Virbac has established itself as a leader in animal health, focusing on the development and production of innovative veterinary products and services.
The company’s core offerings include vaccines, antibiotics, and antiparasitics, all designed to enhance the health and well-being of pets and livestock. What sets Virbac apart is its commitment to research and development, ensuring that its products meet the highest standards of efficacy and safety.
With a strong market position, Virbac has achieved significant milestones, including numerous regulatory approvals and a robust global distribution network, solidifying its reputation as a trusted partner in animal healthcare.
-9 vs industry average
Virbac group’s score of 29 is lower than 44% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Virbac group?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2025
Reported emissions
Scope 3 accounts for ••• of total emissions.
Virbac group's reported carbon emissions
Virbac, a pharmaceutical preparation manufacturing company headquartered in France (FR), reported total emissions of approximately 23.73 million kg CO2e for Scope 1 in 2022. This represents a slight increase from 2021, when Scope 1 emissions were about 20.81 million kg CO2e, and from 2020, with approximately 21.01 million kg CO2e. Prior to this, in 2014, Virbac reported Scope 1 emissions of about 19.19 million kg CO2e, Scope 2 emissions of around 15.01 million kg CO2e, and Scope 3 emissions of approximately 6.82 million kg CO2e, resulting in a total of approximately 41.02 million kg CO2e for that year.
Virbac has set climate commitments with a significant reduction target. The company intends to reduce its Scope 1 and 2 CO2 emissions in absolute value by 30% by 2030, using 2020 as the baseline year. This target covers both Scope 1 and Scope 2 emissions. The company has demonstrated progress on its Scope 1 target for the near term, being on track.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Virbac group’s Climate Goals (2030 & 2050)
2 goals2030
30% reduction in Scope 2
The Group intends to reduce its scope 1 and 2 CO2 emissions in absolute value by 30% by 2030 (compared to 2020)
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
1 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisations
Virbac group
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project